Categories
Connect with us on LinkedIn
Women in Technology: Castor Interview Series 4 – Alexandra Marinescu
Our Women in Technology series continues with Alexandra Marinescu, Product Owner.
Making a Real-World Difference for Patients & Clinical Trials
Learn why myTomorrows utilizes Castor to monitor treatment and assess benefit/risk its users, connecting patients with expanded trial...
Women in Technology: Castor Interview Series 3 – Luciana Mendonça
Our Women in Technology series continues with Luciana Mendonça, Software Engineer.
Women in Technology: Castor Interview Series 2 – Elena Tanturovska
Our Women in Technology series continues with Elena Tanturovska, QA Automation Engineer.
PMCF & RWE: Roles of Medical Device Registry Studies & ePROs
Registry studies focused on a specific medical device are a valuable tool to capture the safety and outcomes...
Castor Inks Big Pharma Deal As Decentralized Trials Business Continues to Show Exponential Growth
Hoboken, New Jersey: March 10, 2021: Castor, a leading provider of clinical trial technology, today announced the signing...
Women in technology: Castor Interview Series, Roxana Cristian
In the Castor D&I interview series, Castorian women in technology share their experiences and thoughts on making the...
Launching a “Remote-first” Universe: Practical Tips from Castor
Castor’s most significant core value is “Achieve anything with a happy and healthy Team,” and so we wanted...
A Guide to Capturing and Managing Data in Digital Therapeutics Trials
This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote...
Why Remote Consent Is the New Normal in 2021
COVID-19 changed the conversation around enrollment and recruitment for clinical trials. Learn how eConsent is helping researchers do...
Advanced Features of Castor EDC for Study Admins
During this webinar you will learn tips and tricks on how to implement some of the advanced features...
Dos and Don’ts for Building Your Study in Castor
In this webinar, we discuss best and worst practices while building a study, when to use specific forms,...
Castor Launches Scalable Decentralized Trial Platform After 383% Commercial Growth
Hoboken, New Jersey: December 17, 2020: Castor, a leading provider of clinical trial technology, today announced the launch...
Top 4 eConsent Questions from Clinical Researchers
In September 2020, Castor CEO Derk Arts, MD, Ph.D., led a webinar on electronic informed consent (eConsent) challenges...
Castor Expands Advisory Board to Support US Growth of Decentralized Clinical Trial Platform
Industry veterans from leading life sciences companies including Johnson & Johnson, Biogen, and Medtronic, will support the Company’s...
eBook: The Decentralized Clinical Trial Playbook
This playbook is a tool for sponsors and CROs who want to leverage DCT technology to support remote...
UKCA Mark: 7 Steps to Prepare Medical Devices for Brexit
In the wake of Brexit, medical device companies secure a UKCA mark as proof of conformity to place...
Decentralized Trial Tech Strategy In Three Steps
Though technologies that support decentralized clinical trials (DCT) have been readily available for years, meaningful industry adoption has...
Connect with us on LinkedIn
